Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cyclophosphamide 4Vincristine 3Rituximab 3Prednisone 3zanubrutinib 2Doxorubicin 2tisagenlecleucel 1sargramostim 1prednylidene 1fludarabine 1deltacortene 1brincidofovir 1axicabtagene ciloleucel 1Methods 1Immunotherapy, Active 1Immunization, Passive 1Epirubicin 1E7777 fusion protein 1Drug Therapy 1Coal Tar 1CT-P10 1Biological Therapy 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Lymphoma, Large B-Cell, Diffuse × E7777 fusion protein × Clear all
NCT04855253 2026-01-15

Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL

Masonic Cancer Center, University of Minnesota

Phase 1/2 Suspended
30 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡